Redeye’s expectation on Q4 results were only slightly higher than reported numbers.
Redeye’s preliminary estimate revisions suggest unchanged sales forecasts and lowered EBIT estimates...
Net sales was 8% above consensus (Infront) in Q4. Clean operating profit was very good in Q4 due to ...
I dag offentliggjorde Spotlight Group sin delårsrapport för det fjärde kvartalet 2021.
Syncro Group publicerade idag den 16 februari 2022 koncernens delårsrapport för fjärde kvartalet 202...
Taaleri reported Q4 EBIT of EUR 14.7m, coming -8% and +1% versus Refinitiv consensus and Nordea, res...
Redeye returns with a more detailed note on the Q4 report following the conference call.
Tjänsteföretaget Coor är en högintressant aktie i osäkra tider, bedömer Analysguiden.
Inga överraskningar Oncozenge presenterade igår sin rapport för det fjärde kvartalet.
OliveCept-aktiviteter gav effkter i Q4 Omsättningen för Q4 uppgick till 10,6 mkr och 14,8 mkr för 20...
Q-linea's announcement regarding the commercial validation study together with the launch partner Th...
Redeye lowers its forecasts and Base Case following a Q4 report with softer ARR growth than expected...
Redeye comments on Safeture's Q4 report, which showed continued recurring revenue growth above the c...
Redeye sees a mixed Q4 report where the ARPC growth is back in solid territory.
Redeye provides its initial take on IRRAS’ Q4 report.
Exel’s Q4 EBIT was soft relative to estimates, yet demand doesn’t seem to abate and in our view the ...
Redeye comments on Starbreeze's year-end report. The result was roughly in line with our estimates.
Redeye comments on Stillfront’s Q4-results which was in line with our expectations and company guida...
Atria reported Q4 adjusted EBIT of EUR 10.3m, 19% below Refinitiv consensus.
Redeye has updated its forecasts, which primarily include near-term adjustments due to the absence o...
